Wednesday, June 2, 2010, 12:00 - 1:00 p.m., MDA 1097
Signature Interdisciplinary Program in Neuroscience Research 2010 Seminar Series
Mike Shelanski, MD, PhD, Francis Delafield Professor of Pathology in the Center for Neurobiology and Behavior and The Taub Institute on Alzheimer’s Disease and the Aging Brain, Columbia University, NY; Chairman of the Department of Pathology, The Taub Institute, will present a seminar on "Caspase 2 and Synaptic Function in AD".
A light lunch will be served. Please confirm your attendance with Heather Weeks (firstname.lastname@example.org or 813-396-9621). Sponsored by the Signature Interdisciplinary Program in Neuroscience Research (SIPN), USF Health. Tuesday, June 15, 2010, 2:00 - 3:00 p.m., MDL 1005
Signature Interdisciplinary Program in Allergy, Immunology and Infectious Disease Distinguished Lecture Series
David B. Weiner, PhD, Professor, Department of Pathology and Laboratory Medicine Chair, Gene Therapy and Vaccine Program, University of Pennsylvania School of Medicine, Philadelphia, PA, will present a seminar on "DNA Vaccines: Rise of the Phoenix".
Sponsored by the Signature Interdisciplinary Program in Allergy, Immunology and Infectious Disease (SIPAIID), USF Health. Thursday, June 17, 2010, 10:30 - 11:30 a.m., Ferman Family Conference Room, Moffitt-Stabile Research Building, first floor
Defense of a Doctoral Dissertation
"Regulatory Mechanism of Myeloid-Derived Suppressor Cell Activity" by Alex Cesar-Corzo (Department of Molecular Medicine). Alex's major professor is Dmitry Gabrilovich, MD, PhD (Departments of Molecular Medicine and Oncologic Sciences).
In anticipation of a successful defense, please attend a celebration at 4:00 p.m. in the MDL courtyard. Thursday, June 17, 2010, 2:30 - 3:30 p.m., Ferman Family Conference Room, Moffitt-Stabile Research Building, first floor
Department of Molecular Medicine Special Seminar
Diana Lopez, PhD, Miller School of Medicine, University of Miami, will present a seminar on "Modulation of myeloid derived suppressor cells is involved in the anti-tumor activity of MUC1/sec".
Sponsored by the Department of Molecular Medicine, College of Medicine, USF Health.